Among synthetic compounds, combinations of senolytic agents such as dasatinib and quercetin have been shown to be effective in selectively eliminating senescent cells and reducing the NF-κB-mediated inflammatory response, promoting bone regeneration and slowing the progression of osteoarthritis [64]. Here, NFKB1 is linked to osteoarthritis.